Evaluation of membrane bioreactor on removal of pharmaceutical micropollutants: a review

Desalination and Water Treatment

Volumn 55, Issue 4, 2015, Pages 845-858

  Li, Chengcheng ^a,b,c   Cabassud, Corinne ^a,b,c   Guigui, Christelle ^a,b,c  

^a INSA   (France)

^b UMR792 INGÉNIERIE DES SYSTÈMES BIOLOGIQUES ET DES PROCÉDÉS   (France)

^c CNRS   (France)

Author keywords

Activated carbon assisted MBR; MBR RO; Membrane bioreactor; Pharmaceutical micropollutants; Wastewater treatment and reuse

Indexed keywords

EID: 84933179529     PISSN: 19443994     EISSN: 19443986     Source Type: Journal    
DOI: 10.1080/19443994.2014.926839     Document Type: Article

References (133)

1. A.D.Levine, T.Asano, Recovering sustainable water from wastewater, Environ. Sci. Technol. 38 (2004) 201A–208A.10.1021/es040504n
2. D.Bixio, C.Thoeye, J.De Koning, D.Joksimovic, D.Savic, T.Wintgens, T.Melin, Wastewater reuse in Europe, Desalination 187 (2006) 89–101.10.1016/j.desal.2005.04.070
3. T.Melin, B.Jefferson, D.Bixio, C.Thoeye, W.De Wilde, J.De Koning, J.Van der Graaf, T.Wintgens, Membrane bioreactor technology for wastewater treatment and reuse, Desalination 187 (2006) 271–282.10.1016/j.desal.2005.04.086
4. S.Judd, The status of membrane bioreactor technology. Trends Biotechnol. 26 (2008) 109–116.10.1016/j.tibtech.2007.11.005
5. H.Lin, F.Wang, L.Ding, H.Hong, J.Chen, X.Lu, Enhanced performance of a submerged membrane bioreactor with powdered activated carbon addition for municipal secondary effluent treatment, J. Hazard. Mater. 192 (2011) 1509–1514.10.1016/j.jhazmat.2011.06.071
6. M.A.Shannon, P.W.Bohn, M.Elimelech, J.G.Georgiadis, B.J.Marinas, A.M.Mayes, Science and technology for water purification in the coming decades, Nature 452 (2008) 301–310.10.1038/nature06599
7. E.L.Farias, K.J.Howe, B.M.Thomson, Effect of membrane bioreactor solids retention time on reverse osmosis membrane fouling for wastewater reuse, Water Res. 49 (2014) 53–61.10.1016/j.watres.2013.11.006
8. R.P.Schwarzenbach, B.I.Escher, K.Fenner, T.B.Hofstetter, C.A.Johnson, U.Von Gunten, B.Wehrli, The challenge of micropollutants in aquatic systems, Science 313 (2006) 1072–1077.10.1126/science.1127291
9. M.Auriol, Y.Filali-Meknassi, R.D.Tyagi, C.D.Adams, R.Y.Surampalli, Endocrine disrupting compounds removal from wastewater, a new challenge, Process Biochem. 41 (2006) 525–539.10.1016/j.procbio.2005.09.017
10. C.G.Daughton, T.A.Ternes, Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect. 107 (1999) 907.10.1289/ehp.99107s6907
11. K.Kümmerer, Drugs in the environment: Emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources—A review, Chemosphere 45 (2001) 957–969.10.1016/S0045-6535(01)00144-8
12. D.W.Kolpin, E.T.Furlong, M.T.Meyer, E.M.Thurman, S.D.Zaugg, L.B.Barber, H.T.Buxton, Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999−2000: A national reconnaissance, Environ. Sci. Technol. 36 (2002) 1202–1211.10.1021/es011055j
13. O.A.Jones, J.N.Lester, N.Voulvoulis, Pharmaceuticals: A threat to drinking water? Trends Biotechnol. 23 (2005) 163–167.10.1016/j.tibtech.2005.02.001
14. B.Halling-Sørensen, S.Nors Nielsen, P.Lanzky, F.Ingerslev, H.Holten Lützhøft, S.Jørgensen, Occurrence, fate and effects of pharmaceutical substances in the environment—A review, Chemosphere 36 (1998) 357–393.10.1016/S0045-6535(97)00354-8
15. N.Le-Minh, S.Khan, J.Drewes, R.Stuetz, Fate of antibiotics during municipal water recycling treatment processes, Water Res. 44 (2010) 4295–4323.10.1016/j.watres.2010.06.020
16. L.H.M.L.M.Santos, A.N.Araújo, A.Fachini, A.Pena, C.Delerue-Matos, M.C.B.S.M.Montenegro, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater. 175 (2010) 45–95.10.1016/j.jhazmat.2009.10.100
17. M.Crane, C.Watts, T.Boucard, Chronic aquatic environmental risks from exposure to human pharmaceuticals, Sci. Tot. Environ. 367 (2006) 23–41.10.1016/j.scitotenv.2006.04.010
18. K.Fent, A.A.Weston, D.Caminada, Ecotoxicology of human pharmaceuticals, Aqua. Toxicol. 76 (2006) 122–159.10.1016/j.aquatox.2005.09.009
19. P.Verlicchi, M.Al Aukidy, E.Zambello, Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review, Sci. Tot. Environ. 429 (2012) 123–155.10.1016/j.scitotenv.2012.04.028
20. B.Petrie, E.J.McAdam, M.D.Scrimshaw, J.N.Lester, E.Cartmell, Fate of drugs during wastewater treatment, TrAC Trends Anal. Chem. 49 (2013) 145–159.10.1016/j.trac.2013.05.007
21. I.Michael, L.Rizzo, C.S.McArdell, C.M.Manaia, C.Merlin, T.Schwartz, C.Dagot, D.Fatta-Kassinos, Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review, Water Res. 47 (2013) 957–995.10.1016/j.watres.2012.11.027
22. S.Suárez, M.Carballa, F.Omil, J.M.Lema, How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters? Rev. Environ. Sci. Biotechnol. 7 (2008) 125–138.10.1007/s11157-008-9130-2
23. T.A.Ternes, A.Joss, H.Siegrist, Peer reviewed: Scrutinizing pharmaceuticals and personal care products in wastewater treatment, Environ. Sci. Technol. 38 (2004) 392A–399A.10.1021/es040639t
24. O.H.Jones, N.Voulvoulis, J.Lester, Human pharmaceuticals in wastewater treatment processes, Crit. Rev. Environ. Sci. Technol. 35 (2005) 401–427.10.1080/10643380590956966
25. Y.Luo, W.Guo, H.H.Ngo, L.D.Nghiem, F.I.Hai, J.Zhang, S.Liang, X.C.Wang, A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment, Sci. Tot. Environ. 473–474 (2014) 619–641.10.1016/j.scitotenv.2013.12.065
26. A.Joss, S.Zabczynski, A.Göbel, B.Hoffmann, D.Löffler, C.S.McArdell, T.A.Ternes, A.Thomsen, H.Siegrist, Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme, Water Res. 40 (2006) 1686–1696.10.1016/j.watres.2006.02.014
27. K.Kümmerer, The presence of pharmaceuticals in the environment due to human use–present knowledge and future challenges, J. Environ. Manage. 90 (2009) 2354–2366.10.1016/j.jenvman.2009.01.023
28. T.A.Ternes, Occurrence of drugs in German sewage treatment plants and rivers, Water Res. 32 (1998) 3245–3260.10.1016/S0043-1354(98)00099-2
29. T.Heberer, Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data, Toxicol. Lett. 131 (2002) 5–17.10.1016/S0378-4274(02)00041-3
30. T.Heberer, D.Feldmann, Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents—modeling versus measurements, J. Hazard. Mater. 122 (2005) 211–218.10.1016/j.jhazmat.2005.03.007
31. C.Ort, M.G.Lawrence, J.Reungoat, G.Eaglesham, S.Carter, J.Keller, Determining the fraction of pharmaceutical residues in wastewater originating from a hospital, Water Res. 44 (2010) 605–615.10.1016/j.watres.2009.08.002
32. P.Verlicchi, M.Al Aukidy, A.Galletti, M.Petrovic, D.Barceló, Hospital effluent: Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment, Sci. Tot. Environ. 430 (2012) 109–118.10.1016/j.scitotenv.2012.04.055
33. J.P.Bound, N.Voulvoulis, Predicted and measured concentrations for selected pharmaceuticals in UK rivers: Implications for risk assessment, Water Res. 40 (2006) 2885–2892.10.1016/j.watres.2006.05.036
34. C.Miège, J.Choubert, L.Ribeiro, M.Eusèbe, M.Coquery, Fate of pharmaceuticals and personal care products in wastewater treatment plants—Conception of a database and first results, Environ. Pollut. 157 (2009) 1721–1726.10.1016/j.envpol.2008.11.045
35. M.Carballa, F.Omil, J.M.Lema, M.A.Llompart, C.Garcı́a-Jares, I.Rodrı́guez, M.Gomez, T.Ternes, Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Res. 38 (2004) 2918–2926.10.1016/j.watres.2004.03.029
36. R.Andreozzi, M.Raffaele, P.Nicklas, Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment, Chemosphere 50 (2003) 1319–1330.10.1016/S0045-6535(02)00769-5
37. J.Santos, I.Aparicio, E.Alonso, Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain), Environ. Int. 33 (2007) 596–601.10.1016/j.envint.2006.09.014
38. M.Stumpf, T.A.Ternes, R.-D.Wilken, S.V.Rodrigues, W.Baumann, Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil, Sci. Tot. Environ. 225 (1999) 135–141.10.1016/S0048-9697(98)00339-8
39. N.Lindqvist, T.Tuhkanen, L.Kronberg, Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Res. 39 (2005) 2219–2228.10.1016/j.watres.2005.04.003
40. J.L.Santos, I.Aparicio, E.Alonso, M.Callejón, Simultaneous determination of pharmaceutically active compounds in wastewater samples by solid phase extraction and high-performance liquid chromatography with diode array and fluorescence detectors, Analyt. Chim. Acta 550 (2005) 116–122.10.1016/j.aca.2005.06.064
41. M.J.Gómez, M.J.Martínez Bueno, S.Lacorte, A.R.Fernández-Alba, A.Agüera, Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast, Chemosphere 66 (2007) 993–1002.10.1016/j.chemosphere.2006.07.051
42. S.S.Verenitch, C.J.Lowe, A.Mazumder, Determination of acidic drugs and caffeine in municipal wastewaters and receiving waters by gas chromatography–ion trap tandem mass spectrometry, J. Chromatogr. A 1116 (2006) 193–203.10.1016/j.chroma.2006.03.005
43. C.I.Kosma, D.A.Lambropoulou, T.A.Albanis, Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece, J. Hazard. Mater. 179 (2010) 804–817.10.1016/j.jhazmat.2010.03.075
44. P.H.Roberts, K.V.Thomas, The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment, Sci. Tot. Environ. 356 (2006) 143–153.10.1016/j.scitotenv.2005.04.031
45. A.Y.-C.Lin, T.-H.Yu, S.K.Lateef, Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan, J. Hazard. Mater. 167 (2009) 1163–1169.10.1016/j.jhazmat.2009.01.108
46. M.J.Hilton, K.V.Thomas, Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography–electrospray tandem mass spectrometry, J. Chromatogr. A 2003 (1015) 129–141.
47. M.Clara, B.Strenn, O.Gans, E.Martinez, N.Kreuzinger, H.Kroiss, Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Res. 39 (2005) 4797–4807.10.1016/j.watres.2005.09.015
48. G.-G.Ying, R.S.Kookana, D.W.Kolpin, Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies, J. Environ. Monit. 11 (2009) 1498–1505.10.1039/b904548a
49. J.L.Santos, I.Aparicio, M.Callejón, E.Alonso, Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain), J. Hazard. Mater. 164 (2009) 1509–1516.10.1016/j.jhazmat.2008.09.073
50. T.Heberer, Tracking persistent pharmaceutical residues from municipal sewage to drinking water, J. Hydrol. 266 (2002) 175–189.10.1016/S0022-1694(02)00165-8
51. M.J.M.Bueno, A.Agüera, M.D.Hernando, M.J.Gómez, A.R.Fernández-Alba, Evaluation of various liquid chromatography-quadrupole-linear ion trap-mass spectrometry operation modes applied to the analysis of organic pollutants in wastewaters, J. Chromatogr. A 1216 (2009) 5995–6002.10.1016/j.chroma.2009.06.047
52. M.Clara, N.Kreuzinger, B.Strenn, O.Gans, H.Kroiss, The solids retention time—A suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants, Water Res. 39 (2005) 97–106.10.1016/j.watres.2004.08.036
53. T.A.Ternes, M.Bonerz, N.Herrmann, B.Teiser, H.R.Andersen, Irrigation of treated wastewater in Braunschweig, Germany: An option to remove pharmaceuticals and musk fragrances, Chemosphere 66 (2007) 894–904.10.1016/j.chemosphere.2006.06.035
54. L.Lishman, S.A.Smyth, K.Sarafin, S.Kleywegt, J.Toito, T.Peart, B.Lee, M.Servos, M.Beland, P.Seto, Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada, Sci. Tot. Environ. 367 (2006) 544–558.10.1016/j.scitotenv.2006.03.021
55. R.Rosal, A.Rodríguez, J.A.Perdigón-Melón, A.Petre, E.García-Calvo, M.J.Gómez, A.Agüera, A.R.Fernández-Alba, Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation, Water Res. 44 (2010) 578–588.10.1016/j.watres.2009.07.004
56. I.Muñoz, M.J.Gómez-Ramos, A.Agüera, A.R.Fernández-Alba, J.F.García-Reyes, A.Molina-Díaz, Chemical evaluation of contaminants in wastewater effluents and the environmental risk of reusing effluents in agriculture, Trends Anal. Chem. 28 (2009) 676–694.
57. B.Kasprzyk-Hordern, R.M.Dinsdale, A.J.Guwy, The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters, Water Res. 43 (2009) 363–380.10.1016/j.watres.2008.10.047
58. C.M.Coetsier, S.Spinelli, L.Lin, B.Roig, E.Touraud, Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs? Environ. Int. 35 (2009) 787–792.10.1016/j.envint.2009.01.008
59. N.Vieno, T.Tuhkanen, L.Kronberg, Elimination of pharmaceuticals in sewage treatment plants in Finland, Water Res. 41 (2007) 1001–1012.10.1016/j.watres.2006.12.017
60. A.Wick, G.Fink, A.Joss, H.Siegrist, T.A.Ternes, Fate of beta blockers and psycho-active drugs in conventional wastewater treatment, Water Res. 43 (2009) 1060–1074.10.1016/j.watres.2008.11.031
61. R.Hirsch, T.Ternes, K.Haberer, K.-L.Kratz, Occurrence of antibiotics in the aquatic environment, Sci. Tot. Environ. 225 (1999) 109–118.10.1016/S0048-9697(98)00337-4
62. W.Xu, G.Zhang, X.Li, S.Zou, P.Li, Z.Hu, J.Li, Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China, Water Res. 41 (2007) 4526–4534.10.1016/j.watres.2007.06.023
63. A.L.Batt, S.Kim, D.S.Aga, Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations, Chemosphere 68 (2007) 428–435.10.1016/j.chemosphere.2007.01.008
64. R.H.Lindberg, P.Wennberg, M.I.Johansson, M.Tysklind, B.A.Andersson, Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden, Environ. Sci. Technol. 39 (2005) 3421–3429.10.1021/es048143z
65. J.E.Renew, C.-H.Huang, Simultaneous determination of fluoroquinolone, sulfonamide, and trimethoprim antibiotics in wastewater using tandem solid phase extraction and liquid chromatography–electrospray mass spectrometry, J. Chromatogr. A 2004 (1042) 113–121.
66. C.Hartig, T.Storm, M.Jekel, Detection and identification of sulphonamide drugs in municipal waste water by liquid chromatography coupled with electrospray ionisation tandem mass spectrometry, J. Chromatogr. A 854 (1999) 163–173.10.1016/S0021-9673(99)00378-7
67. T.A.Larsen, J.Lienert, A.Joss, H.Siegrist, How to avoid pharmaceuticals in the aquatic environment, J. Biotechnol. 113 (2004) 295–304.10.1016/j.jbiotec.2004.03.033
68. J.Sipma, B.Osuna, N.Collado, H.Monclús, G.Ferrero, J.Comas, I.Rodriguez-Roda, Comparison of removal of pharmaceuticals in MBR and activated sludge systems, Desalination 250 (2010) 653–659.10.1016/j.desal.2009.06.073
69. Y.Zhang, S.-U.Geißen, C.Gal, Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies, Chemosphere 73 (2008) 1151–1161.10.1016/j.chemosphere.2008.07.086
70. M.Pomiès, J.-M.Choubert, C.Wisniewski, M.Coquery, Modelling of micropollutant removal in biological wastewater treatments: A review, Sci. Tot. Environ. 443 (2013) 733–748.10.1016/j.scitotenv.2012.11.037
71. E.Sahar, R.Messalem, H.Cikurel, A.Aharoni, A.Brenner, M.Godehardt, M.Jekel, M.Ernst, Fate of antibiotics in activated sludge followed by ultrafiltration (CAS-UF) and in a membrane bioreactor (MBR), Water Res. 45 (2011) 4827–4836.10.1016/j.watres.2011.06.023
72. T.Urase, C.Kagawa, T.Kikuta, Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors, Desalination 178 (2005) 107–113.10.1016/j.desal.2004.11.031
73. R.P.Schwarzenbach, P.Gschwend, D.Imboden, Environmental Organic Chemistry, Wiley-Interscience, Hoboken, 2003.
74. A.A.Alturki, N.Tadkaew, J.A.McDonald, S.J.Khan, W.E.Price, L.D.Nghiem, Combining MBR and NF/RO membrane filtration for the removal of trace organics in indirect potable water reuse applications, J. Membr. Sci. 365 (2010) 206–215.10.1016/j.memsci.2010.09.008
75. d) for pharmaceuticals, estrogens and musk fragrances in digested sludge, Water Res. 42 (2008) 287–295.10.1016/j.watres.2007.07.012
76. M.Cirja, P.Ivashechkin, A.Schäffer, P.F.Corvini, Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR), Rev. Environ. Sci. Biotechnol. 7 (2008) 61–78.10.1007/s11157-007-9121-8
77. A.Joss, E.Keller, A.C.Alder, A.Göbel, C.S.McArdell, T.Ternes, H.Siegrist, Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res. 39 (2005) 3139–3152.10.1016/j.watres.2005.05.031
78. C.Abegglen, A.Joss, C.S.McArdell, G.Fink, M.P.Schlüsener, T.A.Ternes, H.Siegrist, The fate of selected micropollutants in a single-house MBR, Water Res. 43 (2009) 2036–2046.10.1016/j.watres.2009.02.005
79. N.H.Tran, T.Urase, O.Kusakabe, The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds, J. Hazard. Mater. 171 (2009) 1051–1057.10.1016/j.jhazmat.2009.06.114
80. T.Urase, T.Kikuta, Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process, Water Res. 39 (2005) 1289–1300.10.1016/j.watres.2005.01.015
81. d) for pharmaceuticals and musk fragrances in sewage sludge, Water Res. 38 (2004) 4075–4084.10.1016/j.watres.2004.07.015
82. A.Göbel, A.Thomsen, C.S.McArdell, A.Joss, W.Giger, Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment, Environ. Sci. Technol. 39 (2005) 3981–3989.10.1021/es048550a
83. E.M.Golet, I.Xifra, H.Siegrist, A.C.Alder, W.Giger, Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil, Environ. Sci. Technol. 37 (2003) 3243–3249.10.1021/es0264448
84. B.Li, T.Zhang, Biodegradation and adsorption of antibiotics in the activated sludge process, Environ. Sci. Technol. 44 (2010) 3468–3473.10.1021/es903490h
85. J.Radjenović, M.Petrović, D.Barceló, Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment, Water Res. 43 (2009) 831–841.10.1016/j.watres.2008.11.043
86. M.Clara, B.Strenn, N.Kreuzinger, Carbamazepine as a possible anthropogenic marker in the aquatic environment: Investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration, Water Res. 38 (2004) 947–954.10.1016/j.watres.2003.10.058
87. C.Ort, M.G.Lawrence, J.Rieckermann, A.Joss, Sampling for pharmaceuticals and personal care products (PPCPs) and Illicit drugs in wastewater systems: Are your conclusions valid? A critical review, Environ. Sci. Technol. 44 (2010) 6024–6035.10.1021/es100779n
88. A.Göbel, C.S.McArdell, A.Joss, H.Siegrist, W.Giger, Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies, Sci. Tot. Environ. 372 (2007) 361–371.10.1016/j.scitotenv.2006.07.039
89. R.Reif, S.Suárez, F.Omil, J.Lema, Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage, Desalination 221 (2008) 511–517.10.1016/j.desal.2007.01.111
90. M.Bernhard, J.Müller, T.P.Knepper, Biodegradation of persistent polar pollutants in wastewater: Comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment, Water Res. 40 (2006) 3419–3428.10.1016/j.watres.2006.07.011
91. J.B.Quintana, S.Weiss, T.Reemtsma, Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor, Water Res. 39 (2005) 2654–2664.10.1016/j.watres.2005.04.068
92. S.D.Kim, J.Cho, I.S.Kim, B.J.Vanderford, S.A.Snyder, Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters, Water Res. 41 (2007) 1013–1021.10.1016/j.watres.2006.06.034
93. K.C.Wijekoon, F.I.Hai, J.Kang, W.E.Price, W.Guo, H.H.Ngo, L.D.Nghiem, The fate of pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides during MBR treatment, Bioresour. Technol. 144 (2013) 247–254.10.1016/j.biortech.2013.06.097
94. J.Radjenovic, M.Petrovic, D.Barceló, Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor, Analyt. Bioanalyt. Chem. 387 (2007) 1365–1377.10.1007/s00216-006-0883-6
95. L.N.Nguyen, F.I.Hai, J.Kang, W.E.Price, L.D.Nghiem, Coupling granular activated carbon adsorption with membrane bioreactor treatment for trace organic contaminant removal: Breakthrough behaviour of persistent and hydrophilic compounds, J. Environ. Manage. 119 (2013) 173–181.10.1016/j.jenvman.2013.01.037
96. K.Kimura, H.Hara, Y.Watanabe, Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs), Desalination 178 (2005) 135–140.10.1016/j.desal.2004.11.033
97. K.Kimura, H.Hara, Y.Watanabe, Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors, Environ. Sci. Technol. 41 (2007) 3708–3714.10.1021/es061684z
98. L.N.Nguyen, F.I.Hai, J.Kang, W.E.Price, L.D.Nghiem, Removal of trace organic contaminants by a membrane bioreactor–granular activated carbon (MBR–GAC) system, Bioresour. Technol. 113 (2012) 169–173.10.1016/j.biortech.2011.10.051
99. P.Cartagena, M.E.Kaddouri, V.Cases, A.Trapote, D.Prats, Reduction of emerging micropollutants, organic matter, nutrients and salinity from real wastewater by combined MBR-NF/RO treatment, Sep. Purif. Technol. 110 (2013) 132–143.
100. L.N.Nguyen, F.I.Hai, J.Kang, L.D.Nghiem, W.E.Price, W.Guo, H.H.Ngo, K.-L.Tung, Comparison between sequential and simultaneous application of activated carbon with membrane bioreactor for trace organic contaminant removal, Bioresour. Technol. 130 (2013) 412–417.10.1016/j.biortech.2012.11.131
101. N.Tadkaew, F.I.Hai, J.A.McDonald, S.J.Khan, L.D.Nghiem, Removal of trace organics by MBR treatment: the role of molecular properties, Water Res. 45 (2011) 2439–2451.10.1016/j.watres.2011.01.023
102. S.A.Snyder, S.Adham, A.M.Redding, F.S.Cannon, J.DeCarolis, J.Oppenheimer, E.C.Wert, Y.Yoon, Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals, Desalination 202 (2007) 156–181.10.1016/j.desal.2005.12.052
103. S.K.Maeng, B.G.Choi, K.T.Lee, K.G.Song, Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors, Water Res. 47 (2013) 3151–3162.
104. J.L.Tambosi, R.F.de Sena, M.Favier, W.Gebhardt, H.J.José, H.F.Schröder, R.D.F.P.M.Moreira, Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes, Desalination 261 (2010) 148–156.10.1016/j.desal.2010.05.014
105. D.Dolar, M.Gros, S.Rodriguez-Mozaz, J.Moreno, J.Comas, I.Rodriguez-Roda, D.Barceló, Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR–RO, J. Hazard. Mater. 239–240 (2012) 64–69.10.1016/j.jhazmat.2012.03.029
106. F.I.Hai, X.Li, W.E.Price, L.D.Nghiem, Removal of carbamazepine and sulfamethoxazole by MBR under anoxic and aerobic conditions, Bioresour. Technol. 102 (2011) 10386–10390.10.1016/j.biortech.2011.09.019
107. T.Trinh, B.van den Akker, R.Stuetz, H.Coleman, P.Le-Clech, S.Khan, Removal of trace organic chemical contaminants by a membrane bioreactor, Water Sci. Technol. 66 (2012) 1856–1863.10.2166/wst.2012.374
108. L.D.Nghiem, N.Tadkaew, M.Sivakumar, Removal of trace organic contaminants by submerged membrane bioreactors, Desalination 236 (2009) 127–134.10.1016/j.desal.2007.10.059
109. N.Tadkaew, M.Sivakumar, S.J.Khan, J.A.McDonald, L.D.Nghiem, Effect of mixed liquor pH on the removal of trace organic contaminants in a membrane bioreactor, Bioresour. Technol. 101 (2010) 1494–1500.10.1016/j.biortech.2009.09.082
110. V.M.Monsalvo, J.A.McDonald, S.J.Khan, P.Le-Clech, Removal of trace organics by anaerobic membrane bioreactors, Water Res. 49 (2014) 103–112.10.1016/j.watres.2013.11.026
111. N.H.Tran, T.Urase, H.H.Ngo, J.Hu, S.L.Ong, Insight into metabolic and cometabolic activities of autotrophic and heterotrophic microorganisms in the biodegradation of emerging trace organic contaminants, Bioresour. Technol. 146 (2013) 721–731.10.1016/j.biortech.2013.07.083
112. E.Fernandez-Fontaina, F.Omil, J.Lema, M.Carballa, Influence of nitrifying conditions on the biodegradation and sorption of emerging micropollutants, Water Res. 46 (2012) 5434–5444.
113. S.Suarez, J.M.Lema, F.Omil, Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions, Water Res. 44 (2010) 3214–3224.10.1016/j.watres.2010.02.040
114. H.Bouju, G.Buttiglieri, F.Malpei, Perspectives of persistent organic pollutants (POPS) removal in an MBR pilot plant, Desalination 224 (2008) 1–6.10.1016/j.desal.2007.04.071
115. M.Aubenneau, A.Tahar, C.Casellas, C.Wisniewski, Membrane bioreactor for pharmaceutically active compounds removal: Effects of carbamazepine on mixed microbial communities implied in the treatment, Process Biochem. 45 (2010) 1826–1831.10.1016/j.procbio.2010.04.011
116. S.Wang, R.M.Holzem, C.K.Gunsch, Effects of pharmaceutically active compounds on a mixed microbial community originating from a municipal wastewater treatment plant, Environ. Sci. Technol. 42 (2008) 1091–1095.10.1021/es072026x
117. L.F.Delgado, S.Schetrite, C.Gonzalez, C.Albasi, Effect of cytostatic drugs on microbial behaviour in membrane bioreactor system, Bioresour. Technol. 101 (2010) 527–536.10.1016/j.biortech.2009.08.051
118. L.F.Delgado, V.Faucet-Marquis, S.Schetrite, A.Pfohl-Leszkowicz, S.Paranthoen, C.Albasi, Effect of cytostatic drugs on the sludge and on the mixed liquor characteristics of a cross-flow membrane bioreactor: Consequence on the process, J. Membr. Sci. 347 (2010) 165–173.10.1016/j.memsci.2009.10.020
119. A.Avella, L.F.Delgado, T.Görner, C.Albasi, M.Galmiche, P.De Donato, Effect of cytostatic drug presence on extracellular polymeric substances formation in municipal wastewater treated by membrane bioreactor, Bioresour. Technol. 101 (2010) 518–526.10.1016/j.biortech.2009.08.057
120. B.Kraigher, T.Kosjek, E.Heath, B.Kompare, I.Mandic-Mulec, Influence of pharmaceutical residues on the structure of activated sludge bacterial communities in wastewater treatment bioreactors, Water Res. 42 (2008) 4578–4588.10.1016/j.watres.2008.08.006
121. W.C.Lay, Q.Zhang, J.Zhang, D.McDougald, C.Tang, R.Wang, Y.Liu, A.G.Fane, Effect of pharmaceuticals on the performance of a novel osmotic membrane bioreactor (OMBR), Sep. Sci. Technol. 47 (2012) 543–554.10.1080/01496395.2011.630249
122. M.Jacob, Réutilisation des eaux usées épurées par association de procédés biologiques et membranaires [Domestic wastewater reuse by the combination of a bioreactor and membrane processes], PhD Thesis, Insa de Toulouse, Toulouse, 2011.
123. M.M.Huber, A.Göbel, A.Joss, N.Hermann, D.Löffler, C.S.McArdell, A.Ried, H.Siegrist, T.A.Ternes, U.von Gunten, Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: A pilot study, Environ. Sci. Technol. 39 (2005) 4290–4299.10.1021/es048396s
124. L.N.Nguyen, F.I.Hai, J.Kang, W.E.Price, L.D.Nghiem, Removal of emerging trace organic contaminants by MBR-based hybrid treatment processes, Int. Biodeterior. Biodegrad. 85 (2013) 474–482.10.1016/j.ibiod.2013.03.014
125. 2 photocatalysis process for the removal of carbamazepine from simulated pharmaceutical industrial effluent, Bioresour. Technol. 102 (2011) 7012–7015.10.1016/j.biortech.2011.04.056
126. A.Alturki, J.McDonald, S.J.Khan, F.I.Hai, W.E.Price, L.D.Nghiem, Performance of a novel osmotic membrane bioreactor (OMBR) system: Flux stability and removal of trace organics, Bioresour. Technol. 113 (2012) 201–206.10.1016/j.biortech.2012.01.082
127. X.Li, F.I.Hai, L.D.Nghiem, Simultaneous activated carbon adsorption within a membrane bioreactor for an enhanced micropollutant removal, Bioresour. Technol. 102 (2011) 5319–5324.10.1016/j.biortech.2010.11.070
128. L.N.Nguyen, F.I.Hai, L.D.Nghiem, J.Kang, W.E.Price, C.Park, K.Yamamoto, Enhancement of removal of trace organic contaminants by powdered activated carbon dosing into membrane bioreactors, J. Taiwan Inst. Chem. Eng. 45 (2013) 571–578.
129. D.Serrano, S.Suárez, J.Lema, F.Omil, Removal of persistent pharmaceutical micropollutants from sewage by addition of PAC in a sequential membrane bioreactor, Water Res. 45 (2011) 5323–5333.10.1016/j.watres.2011.07.037
130. A.Joss, C.Baenninger, P.Foa, S.Koepke, M.Krauss, C.S.McArdell, K.Rottermann, Y.Wei, A.Zapata, H.Siegrist, Water reuse: >90% water yield in MBR/RO through concentrate recycling and CO2 addition as scaling control, Water Res. 45 (2011) 6141–6151.10.1016/j.watres.2011.09.011
131. E.Sahar, I.David, Y.Gelman, H.Chikurel, A.Aharoni, R.Messalem, A.Brenner, The use of RO to remove emerging micropollutants following CAS/UF or MBR treatment of municipal wastewater, Desalination 273 (2011) 142–147.10.1016/j.desal.2010.11.004
132. L.S.Tam, T.W.Tang, G.N.Lau, K.R.Sharma, G.H.Chen, A pilot study for wastewater reclamation and reuse with MBR/RO and MF/RO systems, Desalination 202 (2007) 106–113.10.1016/j.desal.2005.12.045
133. K.Kimura, T.Iwase, S.Kita, Y.Watanabe, Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes, Water Res. 43 (2009) 3751–3758.10.1016/j.watres.2009.05.042